Description
| Specialty | BIVAL |
|---|---|
| Dosage | 80 mg / 12.5 mg |
| Form | Film-coated tablet |
| Presentation | Box of 30 |
| Primary packaging | Blister |
| Specification | Alu/Alu |
| Active Ingredients (DCI) | Hydrochlorothiazide, Valsartan |
| VEIC Classification | Essential |
| Therapeutic Class | Cardiovascular System |
| Subclass | Agents acting on the renin-angiotensin system |
| Laboratory | PHILADELPHIA PHARMA |
| Table | A |
| Shelf life | 24 months |
| Generic / Brand | Generic |
| Marketing Authorization (AMM) | 9353131 |
| AMM Date | 2015-07-06 |
| Product Range | Cardio-Metabolic Range |







Reviews
There are no reviews yet.